Cargando…
Epigenetics in Brain Tumors: HDACs Take Center Stage
Primary tumors of the brain account for 2 % of all cancers with malignant gliomas taking the lion’s share at 70 %. Malignant gliomas (high grade gliomas WHO° III and °IV) belong to one of the most threatening tumor entities known for their disappointingly short median survival time of just 14 months...
Autores principales: | Eyüpoglu, Ilker Y., Savaskan, Nicolai E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4787285/ https://www.ncbi.nlm.nih.gov/pubmed/26521944 http://dx.doi.org/10.2174/1570159X13666151030162457 |
Ejemplares similares
-
Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight
por: Savaskan, Nicolai E., et al.
Publicado: (2015) -
Dexamethasone Alleviates Tumor-Associated Brain Damage and Angiogenesis
por: Fan, Zheng, et al.
Publicado: (2014) -
A versatile ex vivo technique for assaying tumor angiogenesis and microglia in the brain
por: Ghoochani, Ali, et al.
Publicado: (2015) -
Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment
por: Hatipoglu, Gökçe, et al.
Publicado: (2015) -
Cabazitaxel operates anti-metastatic and cytotoxic via apoptosis induction and stalls brain tumor angiogenesis
por: Ghoochani, Ali, et al.
Publicado: (2016)